Articles

Poll

Podcasts

Slideshows

Videos

Cardiology

Cardiology condition center page is a comprehensive resource for clinical news and insights on cardiovascular and cardiometabolic diseases. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for heart disease and cardiovascular events, as well as associated diabetes, renal failure, and more...

A remote hypertension management program at Mass General Brigham was associated with significant improvements in blood pressure control despite systemic disruptions in care due to the COVID‐19 pandemic.

Remote Hypertension Program Supported Blood Pressure Control During COVID-19 

Children living in areas with greater neighborhood deprivation in the US have a higher likelihood of being diagnosed with primary hypertension, according to an analysis of more than 65,000 children. 

Neighborhood Deprivation Significantly Associated with Hypertension in Youth 

An analysis of data from a 50-year prospective study provides insight into the effects of different pregnancy complications on all-cause mortality later in life. 

Increased Risk of Death Associated with Pregnancy Complications Persists up to 50 Years Later

An analysis of more than 800,000 children with more than 3.5 million person-years of follow-up indicate those in the upper range of average BMI had a 26% greater risk of developing hypertension, with each per unit increase in BMI associated with a 4% increase in risk of hypertension.  

Increased BMI in Childhood Increases Hypertension Risk as an Adult

At ACC 2023, Hoeper provides insight into the key efficacy findings of STELLAR and delves into the safety concerns and generalizability of sotatercept for PAH. 

Marius Hoeper, MD: Insight into STELLAR Trial Investigating Sotatercept for PAH

Hear from Deepak Bhatt, MD, MPH, as he discusses how he interprets the results of the HALO trial and offers perspective on the forthcoming research related to baxdrostat.

HALO Trial: Baxdrostat is Well-Tolerated, But Misses Mark in Uncontrolled Hypertension

Results from the phase 3 A DUE study suggest a combination of macitentan and tadalafil nearly doubled reductions in pulmonary vascular
resistance in patients with PAH. 

Fixed-Dose Combination Pill Bests Monotherapy for Pulmonary Arterial Hypertension

Data from the phase 3 STELLAR trial indicate adding sotatercept to background therapy in PAH was associated with statistically significant  improvements in 6-minute walk distance and 8 of the trial's 9 secondary endpoints, including time to death or clinical worsening. 

STELLAR: Sotatercept Improves Function, Alleviates Disease Burden in Pulmonary Arterial Hypertension

At ACC 2023, HCPLive editorial team sat down with Clyde Yancy, MD, to learn more about his perspective on recent and upcoming advances in cardiovascular care. In this interview, Yancy discusses his perspective on the clinical trial data surrounding renal denervation as a treatment for hypertension.

Clyde Yancy, MD: The Prospect of Renal Denervation for Hypertension

A genome-wide genetic association study using mendelian
randomization provides insight into the causal relationships between HDPs and coronary artery disease and ischemic stroke later in life. 

Study Details Causal Relationship Between Hypertensive Disorders of Pregnancy and Future Cardiovascular Risk

The HCPLive hypertension page is a resource for medical news and expert insights on high blood pressure. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments for hypertension, and more.